NCT01373515View on ClinicalTrials.gov

Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

May 31, 2013

Conditions
Acute Myeloid Leukemia (AML)Leukemic Dendritic Cell Vaccination
Interventions
BIOLOGICAL

DCP-001

4 bi-weekly vaccinations

Trial Locations (1)

Unknown

VU University Medical Center, Amsterdam

Sponsors

Lead Sponsor

Mendus
All Listed Sponsors
lead

Mendus

INDUSTRY

NCT01373515 - Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter